BRCA1 and ovarian carcinoma: The risk of ovarian cancer has been well established in the BRCA 1 and 2 patient population, with lifetime estimates ranging from 22% to 65% for BRCA1 and 10% to 35% for BRCA2 mutation carriers [8,59].